
The drug is used for treatment of infectious diseases such as community acquired pneumonia, exacerbation of chronic bronchitis, acute sinusitis, pharyngitis and skin infections. The active ingredient in Omnicef is cefdinir—a semi-synthetic cephalosporin broad-spectrum antibiotic of the third generation for oral administration. Like other cephalosporin antibiotics, cefdinir has a bactericidal action against susceptible organisms through the inhibition of synthesis of bacteria peptidoglycan cell walls by interfering with the final stage of transamination, required for cross-linking.
Omnicef
Package | pill | Total price | Save | Order |
---|---|---|---|---|
300mg × 30 Pills | $3.18 | $95.28 + Bonus - 4 Pills | - | Add to cart |
300mg × 60 Pills | $2.22 | $133.39 + Bonus - 4 Pills | $57.60 | Add to cart |
300mg × 90 Pills | $1.91 | $171.50 + Bonus - 7 Pills | $114.30 | Add to cart |
300mg × 120 Pills | $1.75 | $209.61 + Bonus - 7 Pills Free Trackable Delivery | $171.60 | Add to cart |
Your order will be packed safely and securely and dispatched within 24 hours. This is exactly how your parcel will look like (pictures of a real shipping item). It has the size and the look of a regular private letter (9.4x4.3x0.3 inches or 24x11x0.7cm), and it does not disclose its contents



Omnicef Product Description
Drug Uses
Omnicef is a cephalosporin antibiotic, used to treat mild to moderate infections in infants, children and adults. Omnicef oral suspension is recommended to be used in infants aged above 6 months, and children under 12 years old for treatment of bacterial infections.
Oral antibiotic Omnicef is characterized by antibacterial action against pathogens, such as:
- Haemophilus influenzae (Hi)
- Haemophilus parainfluenzae (Hpi)
- Moraxella (Branhamella) catarrhalis
- Staphylococcus aureus (S. aureus)
- Streptococcus pneumoniae (pneumococcus)
- Streptococcus pyogenes (S. pyogenes)
Omnicef is effective in treatment of various infectious diseases, including:
- acute maxillary sinusitis*
- tonsillitis and pharyngitis**
- acute otitis media (AOM)***
- community-acquired pneumonia (CAP)*
- acute exacerbations of chronic bronchitis (AECB)*
- uncomplicated skin and skin structure infections (uSSSIs)**
* In patients aged above 13 years (inclusive)
** In patients aged above 6 months
*** In patients aged from 6 months to 12 years (inclusive)
The standard dose of Omnicef for adults is 600mg. The recommended dose of Omnicef for newborns and children under 12 years of age is 14mg per day per kg of the child’s body weight, but not more than 600mg per day. The maximum recommended duration of the antibiotic therapy with Omnicef is 10 days.
Missed Dose
In case you’ve missed a dose of Omnicef, skip the tablet if it is almost time for the next dose of this antibiotic. In other case, use the dose of Omnicef as soon as it is possible.
More Information
For treatment of uSSSIs and CAP in adults and uSSSIs in children, the total daily Omnicef dose should be divided into two intakes. For the treatment of other bacterial infections in children and adults, the daily dose of Omnicef should be taken as a single one.
Storage
Store Omnicef at temperature below 25°C. It is recommended to keep this antibiotic away from moisture, heat and light. Keep capsules Omnicef out of the reach of children.
Omnicef Safety Information
Warnings
Cephalosporin antibiotics (including Omnicef) may cause serious allergic reactions and increase the risk of gastrointestinal infections. In case of symptoms of serious allergies or severe gastrointestinal reactions, the application of Omnicef capsules or oral suspension should be stopped.
Disclaimer
All the material about bacterial infections, published in the review of Omnicef capsules, is for information only and should not be construed to replace the professional medical advice or consultation of the primary care specialist. The online pharmacy takes no responsibility for the damage or loss of any kind, which could happened from using the information about antibiotic Omnicef.
Omnicef Side Effects
Mostly Omnicef is reported to cause mild common adverse events, which intensity can be reduced at decreasing doses or after withdrawal of the antibiotic. Most often, the patients taking Omnicef complain about gastrointestinal adverse events, such as nausea, diarrhea, dyspepsia, abdominal pain or vomiting. Besides, Omnicef may cause other adverse events, including leukopenia, hyperkinesia and rash. In women, this antibiotic may cause vaginitis or vaginal moniliasis.
Antidepressant; a specific inhibitor of serotonin reuptake by neurons of the brain. Has no stimulating or sedative effect, does not affect choline, muscarin-, histamine- and adrenergic processes. The therapeutic effect develops 1-4 weeks after the initiation of therapy.

An antimicrobial agent from the nitrofurans group, especially suitable for the treatment of urinary tract infections and prevention of infections after urologic surgery or examinations (cystoscopy, catheterization, etc.). The medicine disrupts the permeability of the cell membrane and protein synthesis in bacteria.

Calcium channel blocker, a derivative of 1,4-dihydropyridine, has a predominantly cerebrovasculative and antiischemic action. Prescribed for the prevention and treatment of brain ischemia on the background of subarachnoid hemorrhage caused by aneurysm rupture, expressed by brain disfunction in the elderly patients. It can prevent or eliminate spasm of vessels caused by various vasoconstrictor drugs. Improves stability and functional capacity of neurons.

An antineoplastic, antiestrogen remedy. Used to treat breast cancer, mammary gland cancer, carcinoma in situ of the ductal breast cancer; endometrial cancer; estrogenconsisting tumors; adjuvant treatment of breast cancer. It inhibits estrogen receptors competitively in the target organs and tumors originating from these organs.
